Search

everythinglearnresearchcommunity

for

Search:↓

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Men with both baldness and scalp psoriasis often don't have psoriasis on bald spots.

Prostaglandin D2, found in higher levels in bald scalps, stops hair growth, suggesting that blocking its receptor could potentially treat hair loss.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.

Certain proteins are found at higher levels in balding areas compared to non-balding areas, suggesting a link to hair loss. This could be useful for diagnosing and treating hair loss.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Lower growth factors linked to balding in androgenetic alopecia.

TRPS1 loss in balding scalp areas contributes to hair loss in androgenic alopecia.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

The moisturizing cream used after a chemical peel was well tolerated and effectively moisturized the skin.

Two siblings had a rare hair condition with banded hair, which doesn't need treatment.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

IGF-1 affects hair loss and could be a potential treatment.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Dexamethasone may influence hair growth by altering estrogen receptor activity in hair cells.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Minoxidil increases blood flow in balding scalps, possibly reversing hair loss.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

Older East and Southeast Asian men need less hair density for hair restoration satisfaction, and natural hairline features should guide surgery plans.

Found different proteins in balding and non-balding cells, giving insight into hair loss causes.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

Michael L. Beehner proposed a standardized way to describe balding areas on the scalp to help hair restoration experts communicate better.

Michael L. Beehner proposed a standardized naming system for balding scalp areas to help hair restoration surgery.

PGD2 stops hair growth and is higher in bald men with AGA.